Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion
ACS Nano · 18.06.2024 · 18 (24) · 15499-15516
DOI: 10.1021/acsnano.4c00063 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 04.06.2024. Verfasst von Bin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, National Key Laboratory of Innovativ…. Hauptthemen laut MEDLINE: Interleukin-12, RNA, Messenger, Mice, Inbred C57BL. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, National Key Research and Development Program of China, National Center of Technology Innovation for Biopharmaceuticals, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
T cell exhaustion has emerged as a major hurdle that impedes the clinical translation of stimulator of interferon genes (STING) agonists. It is crucial to explore innovative strategies to rejuvenate exhausted T cells and potentiate the antitumor efficacy. Here, we propose an approach utilizing MSA-2 as a STING agonist, along with nanoparticle-mediated delivery of mRNA encoding interleukin-12 (IL-12) to restore the function of T cells. We developed a lipid nanoparticle (DMT7-IL12 LNP) that encapsulated IL12 mRNA. Our findings convincingly demonstrated that the combination of MSA-2 and DMT7-IL12 LNP can effectively reverse the exhausted T cell phenotype, as evidenced by the enhanced secretion of cytokines, such as tumor necrosis factor alpha, interferon gamma, and Granzyme B, coupled with reduced levels of inhibitory molecules such as T cell immunoglobulin and mucin domain-3 and programmed cell death protein-1 on CD8+ T cells. Furthermore, this approach led to improved survival and tumor regression without causing any systemic toxicity in melanoma and lung metastasis models. These findings suggest that mRNA encoding IL-12 in conjunction with STING agonists has the potential to confer superior clinical outcomes, representing a promising advancement in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, School of Pharmaceutical Sciences, National Key Laboratory of Innovative Immunotherapy, Shanghai Jiao Tong University, Shanghai 200240, China.
- Shanghai Institute of Biological Products Co., Ltd., Shanghai 200051, China.
ORCID-Profile: Xiaoyang Xu, Xue-Qing Zhang
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Key Research and Development Program of China
- National Center of Technology Innovation for Biopharmaceuticals, Ministry of Science and Technology of the People's Republic of China
- Shanghai Frontiers Science Center of Drug Target Identification and Delivery, Shanghai Jiao Tong University
Zitieren
APA
Wang, B., Tang, M., Chen, Q., Ho, W., Teng, Y., Xiong, X., Jia, Z., Li, X., Xu, X., & Zhang, X. Q. (2024). Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion. ACS Nano, 18(24), 15499-15516. https://doi.org/10.1021/acsnano.4c00063
Vancouver
Wang B, Tang M, Chen Q, Ho W, Teng Y, Xiong X, et al. Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion. ACS Nano. 2024;18(24):15499-15516. doi:10.1021/acsnano.4c00063
BibTeX
@article{Wang2024,
author = {Wang, Bin and Tang, Maoping and Chen, Qijing and Ho, William and Teng, Yilong and Xiong, Xiaojian and Jia, Zhitong and Li, Xiuling and Xu, Xiaoyang and Zhang, Xue-Qing},
title = {Delivery of mRNA Encoding Interleukin-12 and a Stimulator of Interferon Genes Agonist Potentiates Antitumor Efficacy through Reversing T Cell Exhaustion},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {24},
pages = {15499--15516},
doi = {10.1021/acsnano.4c00063}
}
EUVIMED